Alzheimer disease (AD) research faces challenges to successful enrollment, especially to
clinical trials and biomarker studies. Failure to recruit the planned number of participants in a …

Potential participant registries are tools to address the challenge of slow recruitment to
clinical research. In particular, registries may aid recruitment to secondary prevention clinical …

Clinical trials for Alzheimer's disease (AD) are slower to enroll study participants, take longer
to complete, and are more expensive than trials in most other therapeutic areas. The …

Inefficient and delayed recruitment into clinical trials in Alzheimer disease are major
obstacles impeding progress in the discovery of more effective therapeutic strategies to …

Clinical Alzheimer's disease (AD) trials currently face a critical shortfall of thousands of
eligible participants, which inflates the duration and cost of the clinical study as well as …

The 2012 National Plan to Address Alzheimer's Disease set an ambitious goal: to both
prevent and effectively treat Alzheimer's disease by 2025. To reach this goal, tens of …

Background: Low participation in clinical trials is a major challenge to advancing clinical
Alzheimer's disease (AD) research and care. Factors influencing recruitment to AD trials are …

Background The identification and enlistment of suitable participants into clinical studies is
often challenging, requiring a large commitment of time and staff resources. The recruitment …

In light of our limited understanding of what motivates older adults to participate in clinical
studies of Alzheimer's disease (AD), the current study examines incentives and barriers to …

Abstract Background Recruitment for Alzheimer's disease (AD)-focused studies, particularly
prevention studies, is challenging due to the public's lack of awareness about study …